evadyne tablets 10 milligram
john wyeth & brother limited - butriptyline hydrochloride - tablets - 10 milligram
evadyne tablets 25 milligram
john wyeth & brother limited - butriptyline hydrochloride - tablets - 25 milligram
evadyne tablets 50 milligram
john wyeth & brother limited - butriptyline hydrochloride - tablets - 50 milligram
evadyne tablets 75 milligram
ayerst laboratories limited - butriptyline hydrochloride - tablets - 75 milligram
isocarboxazid 10mg tablets
a a h pharmaceuticals ltd - isocarboxazid - oral tablet - 10mg
isocarboxazid 10mg tablets
alliance pharmaceuticals ltd - isocarboxazid - oral tablet - 10mg
isocarboxazid 10mg tablets
alliance healthcare (distribution) ltd - isocarboxazid - oral tablet - 10mg
isocarboxazid 10mg tablets
ennogen healthcare ltd - isocarboxazid - oral tablet - 10mg
nortriptyline hydrochloride capsule
avpak - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome ( see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.
nortriptyline hydrochloride capsule
nucare pharmaceuticals, inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 25 mg - nortriptyline hydrochloride, usp is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see w arnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). hypersensitivity to tricyclic antide